Choosing the proper animal model for oral submucous fibrosis research: considerations and challenges. [PDF]
Zhang L, Chen J, Li F, Liu B, Liu J.
europepmc +1 more source
Retraction: VEGF gene transfection restores the angiogenesis of oral submucous fibrosis in mice. [PDF]
Sun Y, Wang T, Wen QT, Yu DH, Chen JX.
europepmc +1 more source
Metformin alleviates the progression of oral submucous fibrosis through downregulation of metastasis associated lung adenocarcinoma transcript 1 (MALAT1). [PDF]
Hsieh PL +5 more
europepmc +1 more source
Diagnosing malignant transformation potential in oral submucous fibrosis with leukoplakia: an approach utilizing deoxyribonucleic acid image cytometry. [PDF]
Li H +8 more
europepmc +1 more source
Novel transcripts of EMT driving the malignant transformation of oral submucous fibrosis. [PDF]
Shetty SS +5 more
europepmc +1 more source
MicroRNA let-7a mitigates the progression of oral submucous fibrosis by targeting high-mobility group AT-hook 2. [PDF]
Yang HW +5 more
europepmc +1 more source
Glutathione S-transferase M1 and T1 null polymorphisms and risk of oral submucous fibrosis: a meta-analysis of South Asian populations. [PDF]
Motahari P, Neshanifard N.
europepmc +1 more source
Epigallocatechin-3-gallate inhibits the collagen accumulation of oral submucous fibrosis induced by arecoline. [PDF]
Gao G, Lin C, Li R, Xie X, Luo HB.
europepmc +1 more source
Prognostic Significance of Genetic Polymorphisms rs3819024 (A/G) of Interleukin-17A Gene and rs763780 (C/T) of Interleukin-17F Gene in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma. [PDF]
Saha SS, Mahato B, Prodhan C, Deb T.
europepmc +1 more source

